Serena Williams caught the eye as she walked the red carpet for the premiere of Gucci’s short film, The Tiger, in Milan, with ...

Oral Ozempic alternative Orforglipron inspired the biggest biotech investment in Texas history, in Generation Park.

“Semaglutide hits one receptor. It was the first one that came out,” Dr. Howe said. “Tirzepatide hits two receptors, and ...

Pfizer is expediting its efforts to delve into the growing obesity treatment field with a nearly $5 billion acquisition. The ...

Delve into Eli Lilly’s biopharma strategy as it advances its pipeline, wins regulatory milestones, and forges strategic deals ...

Eli Lilly will make its next-generation experimental weight-loss pill, orforglipron, at a new multi-billion-dollar ...

The multibillion-dollar investment will result in more than 600 permanent jobs, according to the company. The manufacturing ...

Eli Lilly said it plans to build a $6.5 billion facility in Houston to make active pharmaceutical ingredients, including for a new oral weight-loss drug. The plant will bring 615 jobs to the area, ...

The $6.5 billion Houston-area plant is part of the drugmaker’s commitment to add four U.S. manufacturing sites through a $27 ...

FDA cites Catalent Indiana issues in Scholar Rock's SMA drug review; European approval decision expected in 2026, with ...

Millions of Americans who could benefit from GLP-1 weight-loss drugs are caught in the middle of a battle between drug ...